Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Current Assets: 2021-2025

Historic Current Assets for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $1.1 billion.

  • Core Scientific's Current Assets rose 281.86% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 281.86%. This contributed to the annual value of $904.0 million for FY2024, which is 831.77% up from last year.
  • Latest data reveals that Core Scientific reported Current Assets of $1.1 billion as of Q3 2025, which was up 5.60% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Current Assets ranged from a high of $1.1 billion in Q3 2025 and a low of $2.0 million during Q3 2021.
  • Its 3-year average for Current Assets is $435.0 million, with a median of $143.3 million in 2024.
  • The largest annual percentage gain for Core Scientific's Current Assets in the last 5 years was 29,480.72% (2022), contrasted with its biggest fall of 88.75% (2022).
  • Core Scientific's Current Assets (Quarterly) stood at $756.6 million in 2021, then tumbled by 88.75% to $85.1 million in 2022, then climbed by 14.00% to $97.0 million in 2023, then soared by 831.77% to $904.0 million in 2024, then spiked by 281.86% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.0 billion for Q2 2025, and $833.2 million during Q1 2025.